Correction: Tumor-penetrating peptide boosts bispecific T-cell engager antitumor efficacy for the pancreatic cancer
Authors
- M. Li
- X. H. Bai (ORCID: https://orcid.org/0009-0006-9737-2880)
- Subiyinuer Tuerhong
- Qiaoli Wang (ORCID: https://orcid.org/0000-0003-1189-8349)
- Lu Zou
- F Q Meng
- Yanru Wang (ORCID: https://orcid.org/0000-0001-8272-2450)
- Jingjing Chen
- Juan Du
- Qinghua Zheng
- Changchang Lu
Institutions
- Nanjing Drum Tower Hospital (CN)
- Zhejiang University (CN)
- Nanjing University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-01-07
- DOI
- https://doi.org/10.3389/fimmu.2025.1772783
- Primary Topic
- Monoclonal and Polyclonal Antibodies Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Jiangsu Commission of Health
- National Natural Science Foundation of China